ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global On-body Injectors Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-31F6775
Home | Market Reports | Autos & Vehicles| Vehicle Parts & Services| Vehicle Parts & Accessories
Global On body Injectors Market Insights and Forecast to 2028
BUY CHAPTERS

Global On-body Injectors Market Research Report 2025

Code: QYRE-Auto-31F6775
Report
March 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Insulet
Ypsomed
Enable Injections
West Pharmaceutical Services
Gerresheimer
United Therapeutics
CC Bio
BD
Nemera
Stevanato Group S.p.A.
Sonceboz
Lohmann Therapie-Systeme
Elcam Drug Delivery Devices (E3D)

On-body Injectors Market Size

The global market for On-body Injectors was valued at US$ 176 million in the year 2024 and is projected to reach a revised size of US$ 462 million by 2031, growing at a CAGR of 15.0% during the forecast period.

On-body Injectors Market

On-body Injectors Market

On-body injectors, also known as on-body delivery systems (OBDS), are medical devices designed to deliver a controlled dose of medication or therapeutic substances subcutaneously (under the skin) over a specified period. These devices are typically worn on the body and are used to administer various treatments, including medications, hormones, and biologics. On-body injectors offer several advantages, including increased patient convenience, improved medication adherence, and the ability to deliver complex therapies.
The scope of this report is non-insulin On-body injectors.
In the global market, On-body Injectors is dominated by core players such as AWest Pharmaceutical Services, Insulet, Gerresheimer, ect. The top three players within this industry account for about 80% of the market share. North America, Europe, and Asia-Pacific are the major manufacturing regions for this product, and they all hold about 15% of the global market share. The product can be categorised on the basis of product type into electronic syringes and mechanical syringes. The product is widely used in the treatment of oncology immunology, cardiovascular diseases, neurological disorders, and other diseases.

Report Scope

This report aims to provide a comprehensive presentation of the global market for On-body Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding On-body Injectors.
The On-body Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global On-body Injectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the On-body Injectors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of On-body Injectors Market Report

Report Metric Details
Report Name On-body Injectors Market
Accounted market size in year US$ 176 million
Forecasted market size in 2031 US$ 462 million
CAGR 15.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company West Pharmaceutical Services, Insulet, Gerresheimer, United Therapeutics, CC Bio, BD, Ypsomed, Enable Injections, Nemera, Stevanato Group, Sonceboz, Lohmann Therapie-Systeme, Elcam Drug Delivery Devices (E3D)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of On-body Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of On-body Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is On-body Injectors Market growing?

Ans: The On-body Injectors Market witnessing a CAGR of 15.0% during the forecast period 2025-2031.

What is the On-body Injectors Market size in 2031?

Ans: The On-body Injectors Market size in 2031 will be US$ 462 million.

What is the market share of major companies in On-body Injectors Market?

Ans: The top three players within this industry account for about 80% of the market share.

Who are the main players in the On-body Injectors Market report?

Ans: The main players in the On-body Injectors Market are West Pharmaceutical Services, Insulet, Gerresheimer, United Therapeutics, CC Bio, BD, Ypsomed, Enable Injections, Nemera, Stevanato Group, Sonceboz, Lohmann Therapie-Systeme, Elcam Drug Delivery Devices (E3D)

What are the Application segmentation covered in the On-body Injectors Market report?

Ans: The Applications covered in the On-body Injectors Market report are Immuno-oncology, Cardiovascular Diseases, Neurological Diseases, Others

What are the Type segmentation covered in the On-body Injectors Market report?

Ans: The Types covered in the On-body Injectors Market report are Electronic Injectors, Mechanical Injectors

Recommended Reports

Wearable Injectors

Drug Delivery Devices

Diagnostics & Therapy

1 On-body Injectors Market Overview
1.1 Product Definition
1.2 On-body Injectors by Type
1.2.1 Global On-body Injectors Market Value Comparison by Type (2024 VS 2031)
1.2.2 Electronic Injectors
1.2.3 Mechanical Injectors
1.3 On-body Injectors by Application
1.3.1 Global On-body Injectors Market Value by Application (2024 VS 2031)
1.3.2 Immuno-oncology
1.3.3 Cardiovascular Diseases
1.3.4 Neurological Diseases
1.3.5 Others
1.4 Global On-body Injectors Market Size Estimates and Forecasts
1.4.1 Global On-body Injectors Revenue 2020-2031
1.4.2 Global On-body Injectors Sales 2020-2031
1.4.3 Global On-body Injectors Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 On-body Injectors Market Competition by Manufacturers
2.1 Global On-body Injectors Sales Market Share by Manufacturers (2020-2025)
2.2 Global On-body Injectors Revenue Market Share by Manufacturers (2020-2025)
2.3 Global On-body Injectors Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of On-body Injectors, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of On-body Injectors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of On-body Injectors, Product Type & Application
2.7 Global Key Manufacturers of On-body Injectors, Date of Enter into This Industry
2.8 Global On-body Injectors Market Competitive Situation and Trends
2.8.1 Global On-body Injectors Market Concentration Rate
2.8.2 The Global 5 and 10 Largest On-body Injectors Players Market Share by Revenue
2.8.3 Global On-body Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global On-body Injectors Market Scenario by Region
3.1 Global On-body Injectors Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global On-body Injectors Sales by Region: 2020-2031
3.2.1 Global On-body Injectors Sales by Region: 2020-2025
3.2.2 Global On-body Injectors Sales by Region: 2026-2031
3.3 Global On-body Injectors Revenue by Region: 2020-2031
3.3.1 Global On-body Injectors Revenue by Region: 2020-2025
3.3.2 Global On-body Injectors Revenue by Region: 2026-2031
3.4 North America On-body Injectors Market Facts & Figures by Country
3.4.1 North America On-body Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America On-body Injectors Sales by Country (2020-2031)
3.4.3 North America On-body Injectors Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe On-body Injectors Market Facts & Figures by Country
3.5.1 Europe On-body Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe On-body Injectors Sales by Country (2020-2031)
3.5.3 Europe On-body Injectors Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific On-body Injectors Market Facts & Figures by Region
3.6.1 Asia Pacific On-body Injectors Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific On-body Injectors Sales by Region (2020-2031)
3.6.3 Asia Pacific On-body Injectors Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America On-body Injectors Market Facts & Figures by Country
3.7.1 Latin America On-body Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America On-body Injectors Sales by Country (2020-2031)
3.7.3 Latin America On-body Injectors Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa On-body Injectors Market Facts & Figures by Country
3.8.1 Middle East and Africa On-body Injectors Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa On-body Injectors Sales by Country (2020-2031)
3.8.3 Middle East and Africa On-body Injectors Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global On-body Injectors Sales by Type (2020-2031)
4.1.1 Global On-body Injectors Sales by Type (2020-2025)
4.1.2 Global On-body Injectors Sales by Type (2026-2031)
4.1.3 Global On-body Injectors Sales Market Share by Type (2020-2031)
4.2 Global On-body Injectors Revenue by Type (2020-2031)
4.2.1 Global On-body Injectors Revenue by Type (2020-2025)
4.2.2 Global On-body Injectors Revenue by Type (2026-2031)
4.2.3 Global On-body Injectors Revenue Market Share by Type (2020-2031)
4.3 Global On-body Injectors Price by Type (2020-2031)
5 Segment by Application
5.1 Global On-body Injectors Sales by Application (2020-2031)
5.1.1 Global On-body Injectors Sales by Application (2020-2025)
5.1.2 Global On-body Injectors Sales by Application (2026-2031)
5.1.3 Global On-body Injectors Sales Market Share by Application (2020-2031)
5.2 Global On-body Injectors Revenue by Application (2020-2031)
5.2.1 Global On-body Injectors Revenue by Application (2020-2025)
5.2.2 Global On-body Injectors Revenue by Application (2026-2031)
5.2.3 Global On-body Injectors Revenue Market Share by Application (2020-2031)
5.3 Global On-body Injectors Price by Application (2020-2031)
6 Key Companies Profiled
6.1 West Pharmaceutical Services
6.1.1 West Pharmaceutical Services Company Information
6.1.2 West Pharmaceutical Services Description and Business Overview
6.1.3 West Pharmaceutical Services On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.1.4 West Pharmaceutical Services On-body Injectors Product Portfolio
6.1.5 West Pharmaceutical Services Recent Developments/Updates
6.2 Insulet
6.2.1 Insulet Company Information
6.2.2 Insulet Description and Business Overview
6.2.3 Insulet On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Insulet On-body Injectors Product Portfolio
6.2.5 Insulet Recent Developments/Updates
6.3 Gerresheimer
6.3.1 Gerresheimer Company Information
6.3.2 Gerresheimer Description and Business Overview
6.3.3 Gerresheimer On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Gerresheimer On-body Injectors Product Portfolio
6.3.5 Gerresheimer Recent Developments/Updates
6.4 United Therapeutics
6.4.1 United Therapeutics Company Information
6.4.2 United Therapeutics Description and Business Overview
6.4.3 United Therapeutics On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.4.4 United Therapeutics On-body Injectors Product Portfolio
6.4.5 United Therapeutics Recent Developments/Updates
6.5 CC Bio
6.5.1 CC Bio Company Information
6.5.2 CC Bio Description and Business Overview
6.5.3 CC Bio On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CC Bio On-body Injectors Product Portfolio
6.5.5 CC Bio Recent Developments/Updates
6.6 BD
6.6.1 BD Company Information
6.6.2 BD Description and Business Overview
6.6.3 BD On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BD On-body Injectors Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 Ypsomed
6.7.1 Ypsomed Company Information
6.7.2 Ypsomed Description and Business Overview
6.7.3 Ypsomed On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ypsomed On-body Injectors Product Portfolio
6.7.5 Ypsomed Recent Developments/Updates
6.8 Enable Injections
6.8.1 Enable Injections Company Information
6.8.2 Enable Injections Description and Business Overview
6.8.3 Enable Injections On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Enable Injections On-body Injectors Product Portfolio
6.8.5 Enable Injections Recent Developments/Updates
6.9 Nemera
6.9.1 Nemera Company Information
6.9.2 Nemera Description and Business Overview
6.9.3 Nemera On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Nemera On-body Injectors Product Portfolio
6.9.5 Nemera Recent Developments/Updates
6.10 Stevanato Group
6.10.1 Stevanato Group Company Information
6.10.2 Stevanato Group Description and Business Overview
6.10.3 Stevanato Group On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Stevanato Group On-body Injectors Product Portfolio
6.10.5 Stevanato Group Recent Developments/Updates
6.11 Sonceboz
6.11.1 Sonceboz Company Information
6.11.2 Sonceboz Description and Business Overview
6.11.3 Sonceboz On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sonceboz On-body Injectors Product Portfolio
6.11.5 Sonceboz Recent Developments/Updates
6.12 Lohmann Therapie-Systeme
6.12.1 Lohmann Therapie-Systeme Company Information
6.12.2 Lohmann Therapie-Systeme Description and Business Overview
6.12.3 Lohmann Therapie-Systeme On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Lohmann Therapie-Systeme On-body Injectors Product Portfolio
6.12.5 Lohmann Therapie-Systeme Recent Developments/Updates
6.13 Elcam Drug Delivery Devices (E3D)
6.13.1 Elcam Drug Delivery Devices (E3D) Company Information
6.13.2 Elcam Drug Delivery Devices (E3D) Description and Business Overview
6.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Elcam Drug Delivery Devices (E3D) On-body Injectors Product Portfolio
6.13.5 Elcam Drug Delivery Devices (E3D) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 On-body Injectors Industry Chain Analysis
7.2 On-body Injectors Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 On-body Injectors Production Mode & Process Analysis
7.4 On-body Injectors Sales and Marketing
7.4.1 On-body Injectors Sales Channels
7.4.2 On-body Injectors Distributors
7.5 On-body Injectors Customer Analysis
8 On-body Injectors Market Dynamics
8.1 On-body Injectors Industry Trends
8.2 On-body Injectors Market Drivers
8.3 On-body Injectors Market Challenges
8.4 On-body Injectors Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Insulet
Ypsomed
Enable Injections
West Pharmaceutical Services
Gerresheimer
United Therapeutics
CC Bio
BD
Nemera
Stevanato Group S.p.A.
Sonceboz
Lohmann Therapie-Systeme
Elcam Drug Delivery Devices (E3D)
List of Tables
 Table 1. Global On-body Injectors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global On-body Injectors Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global On-body Injectors Market Competitive Situation by Manufacturers in 2024
 Table 4. Global On-body Injectors Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global On-body Injectors Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global On-body Injectors Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global On-body Injectors Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market On-body Injectors Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of On-body Injectors, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of On-body Injectors, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of On-body Injectors, Product Type & Application
 Table 12. Global Key Manufacturers of On-body Injectors, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global On-body Injectors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in On-body Injectors as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global On-body Injectors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global On-body Injectors Sales by Region (2020-2025) & (K Units)
 Table 18. Global On-body Injectors Sales Market Share by Region (2020-2025)
 Table 19. Global On-body Injectors Sales by Region (2026-2031) & (K Units)
 Table 20. Global On-body Injectors Sales Market Share by Region (2026-2031)
 Table 21. Global On-body Injectors Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global On-body Injectors Revenue Market Share by Region (2020-2025)
 Table 23. Global On-body Injectors Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global On-body Injectors Revenue Market Share by Region (2026-2031)
 Table 25. North America On-body Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America On-body Injectors Sales by Country (2020-2025) & (K Units)
 Table 27. North America On-body Injectors Sales by Country (2026-2031) & (K Units)
 Table 28. North America On-body Injectors Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America On-body Injectors Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe On-body Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe On-body Injectors Sales by Country (2020-2025) & (K Units)
 Table 32. Europe On-body Injectors Sales by Country (2026-2031) & (K Units)
 Table 33. Europe On-body Injectors Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe On-body Injectors Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific On-body Injectors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific On-body Injectors Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific On-body Injectors Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific On-body Injectors Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific On-body Injectors Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America On-body Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America On-body Injectors Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America On-body Injectors Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America On-body Injectors Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America On-body Injectors Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa On-body Injectors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa On-body Injectors Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa On-body Injectors Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa On-body Injectors Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa On-body Injectors Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global On-body Injectors Sales (K Units) by Type (2020-2025)
 Table 51. Global On-body Injectors Sales (K Units) by Type (2026-2031)
 Table 52. Global On-body Injectors Sales Market Share by Type (2020-2025)
 Table 53. Global On-body Injectors Sales Market Share by Type (2026-2031)
 Table 54. Global On-body Injectors Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global On-body Injectors Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global On-body Injectors Revenue Market Share by Type (2020-2025)
 Table 57. Global On-body Injectors Revenue Market Share by Type (2026-2031)
 Table 58. Global On-body Injectors Price (US$/Unit) by Type (2020-2025)
 Table 59. Global On-body Injectors Price (US$/Unit) by Type (2026-2031)
 Table 60. Global On-body Injectors Sales (K Units) by Application (2020-2025)
 Table 61. Global On-body Injectors Sales (K Units) by Application (2026-2031)
 Table 62. Global On-body Injectors Sales Market Share by Application (2020-2025)
 Table 63. Global On-body Injectors Sales Market Share by Application (2026-2031)
 Table 64. Global On-body Injectors Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global On-body Injectors Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global On-body Injectors Revenue Market Share by Application (2020-2025)
 Table 67. Global On-body Injectors Revenue Market Share by Application (2026-2031)
 Table 68. Global On-body Injectors Price (US$/Unit) by Application (2020-2025)
 Table 69. Global On-body Injectors Price (US$/Unit) by Application (2026-2031)
 Table 70. West Pharmaceutical Services Company Information
 Table 71. West Pharmaceutical Services Description and Business Overview
 Table 72. West Pharmaceutical Services On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. West Pharmaceutical Services On-body Injectors Product
 Table 74. West Pharmaceutical Services Recent Developments/Updates
 Table 75. Insulet Company Information
 Table 76. Insulet Description and Business Overview
 Table 77. Insulet On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Insulet On-body Injectors Product
 Table 79. Insulet Recent Developments/Updates
 Table 80. Gerresheimer Company Information
 Table 81. Gerresheimer Description and Business Overview
 Table 82. Gerresheimer On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Gerresheimer On-body Injectors Product
 Table 84. Gerresheimer Recent Developments/Updates
 Table 85. United Therapeutics Company Information
 Table 86. United Therapeutics Description and Business Overview
 Table 87. United Therapeutics On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. United Therapeutics On-body Injectors Product
 Table 89. United Therapeutics Recent Developments/Updates
 Table 90. CC Bio Company Information
 Table 91. CC Bio Description and Business Overview
 Table 92. CC Bio On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. CC Bio On-body Injectors Product
 Table 94. CC Bio Recent Developments/Updates
 Table 95. BD Company Information
 Table 96. BD Description and Business Overview
 Table 97. BD On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. BD On-body Injectors Product
 Table 99. BD Recent Developments/Updates
 Table 100. Ypsomed Company Information
 Table 101. Ypsomed Description and Business Overview
 Table 102. Ypsomed On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Ypsomed On-body Injectors Product
 Table 104. Ypsomed Recent Developments/Updates
 Table 105. Enable Injections Company Information
 Table 106. Enable Injections Description and Business Overview
 Table 107. Enable Injections On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Enable Injections On-body Injectors Product
 Table 109. Enable Injections Recent Developments/Updates
 Table 110. Nemera Company Information
 Table 111. Nemera Description and Business Overview
 Table 112. Nemera On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Nemera On-body Injectors Product
 Table 114. Nemera Recent Developments/Updates
 Table 115. Stevanato Group Company Information
 Table 116. Stevanato Group Description and Business Overview
 Table 117. Stevanato Group On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Stevanato Group On-body Injectors Product
 Table 119. Stevanato Group Recent Developments/Updates
 Table 120. Sonceboz Company Information
 Table 121. Sonceboz Description and Business Overview
 Table 122. Sonceboz On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Sonceboz On-body Injectors Product
 Table 124. Sonceboz Recent Developments/Updates
 Table 125. Lohmann Therapie-Systeme Company Information
 Table 126. Lohmann Therapie-Systeme Description and Business Overview
 Table 127. Lohmann Therapie-Systeme On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Lohmann Therapie-Systeme On-body Injectors Product
 Table 129. Lohmann Therapie-Systeme Recent Developments/Updates
 Table 130. Elcam Drug Delivery Devices (E3D) Company Information
 Table 131. Elcam Drug Delivery Devices (E3D) Description and Business Overview
 Table 132. Elcam Drug Delivery Devices (E3D) On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Elcam Drug Delivery Devices (E3D) On-body Injectors Product
 Table 134. Elcam Drug Delivery Devices (E3D) Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. On-body Injectors Distributors List
 Table 138. On-body Injectors Customers List
 Table 139. On-body Injectors Market Trends
 Table 140. On-body Injectors Market Drivers
 Table 141. On-body Injectors Market Challenges
 Table 142. On-body Injectors Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of On-body Injectors
 Figure 2. Global On-body Injectors Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global On-body Injectors Market Share by Type: 2024 & 2031
 Figure 4. Electronic Injectors Product Picture
 Figure 5. Mechanical Injectors Product Picture
 Figure 6. Global On-body Injectors Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global On-body Injectors Market Share by Application: 2024 & 2031
 Figure 8. Immuno-oncology
 Figure 9. Cardiovascular Diseases
 Figure 10. Neurological Diseases
 Figure 11. Others
 Figure 12. Global On-body Injectors Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global On-body Injectors Market Size (2020-2031) & (US$ Million)
 Figure 14. Global On-body Injectors Sales (2020-2031) & (K Units)
 Figure 15. Global On-body Injectors Average Price (US$/Unit) & (2020-2031)
 Figure 16. On-body Injectors Report Years Considered
 Figure 17. On-body Injectors Sales Share by Manufacturers in 2024
 Figure 18. Global On-body Injectors Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest On-body Injectors Players: Market Share by Revenue in On-body Injectors in 2024
 Figure 20. On-body Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global On-body Injectors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America On-body Injectors Sales Market Share by Country (2020-2031)
 Figure 23. North America On-body Injectors Revenue Market Share by Country (2020-2031)
 Figure 24. United States On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe On-body Injectors Sales Market Share by Country (2020-2031)
 Figure 27. Europe On-body Injectors Revenue Market Share by Country (2020-2031)
 Figure 28. Germany On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific On-body Injectors Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific On-body Injectors Revenue Market Share by Region (2020-2031)
 Figure 35. China On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America On-body Injectors Sales Market Share by Country (2020-2031)
 Figure 43. Latin America On-body Injectors Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa On-body Injectors Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa On-body Injectors Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE On-body Injectors Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of On-body Injectors by Type (2020-2031)
 Figure 53. Global Revenue Market Share of On-body Injectors by Type (2020-2031)
 Figure 54. Global On-body Injectors Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of On-body Injectors by Application (2020-2031)
 Figure 56. Global Revenue Market Share of On-body Injectors by Application (2020-2031)
 Figure 57. Global On-body Injectors Price (US$/Unit) by Application (2020-2031)
 Figure 58. On-body Injectors Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Subcutaneous Medicine Delivery Devices Market Research Report 2024
Wearable Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global On body Drug Delivery Devices Market Research Report 2025
Global Aesthetics Intradermal Injection Devices Market Research Report 2024
Global Needle free Drug Injectors Market Research Report 2024
Global Advanced Infusion Systems Market Research Report 2024
Global Injectable Drug Delivery Market Research Report 2024
Global Intradermal Injection Device Market Research Report 2025
On Body Delivery System OBDS Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Wearable Injector Devices Market Insights Forecast to 2030
On Body Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Wearable Patch Injector Market Research Report 2024
Global Ultra large Volume Wearable Injectors Market Research Report 2024
Global Biologic Injectors Market Research Report 2024
Global Off body Wearable Injectors Market Research Report 2024
Global Mesotherapy Injector Market Research Report 2025
Global Jet Injector Device Market Research Report 2024
Implantable Drug Delivery Devices Market
Global Automated Infusion Pumps Market Research Report 2024
Global On board Diagnostic OBD Systems For Heavy duty Vehicles Market Research Report 2024

RELATED REPORTS

Global Torque Converter for Passenger Car Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16O17666
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Vehicle Interior Synthetic Leather Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0L17591
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Torque Converter for Passenger Vehicle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22H7735
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Automotive Wiring Harness Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36H1665
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions